About Zina Affas Besse
Zina Affas Besse is a director at Imbria Pharmaceuticals.
Form D filings also name Zina Affas Besse as a director, phd at Eyenuk and a director at Axena Health.
Zina Affas Besse first appears on SEC filings in 2022.
Experience
This experience comes from Zina Affas Besse's profile and from SEC filings. For roles taken from filings, the years are when the filings name Zina Affas Besse in the role, so the role may have started earlier or lasted longer.
BM
BNP Paribas Asset Management Current
Partner and Deputy Head of Healthcare Private Equity
2026 – Present
RE
ReproNovo Current
Board Member
2025 – Present
Axena Health, Inc. Current
Director
2023 – Present · Auburndale, MA
Makes an at-home pelvic floor training device for women with bladder or bowel leakage.
LA
LimmaTech Biologics AG Current
Board Member
2023 – Present
Eyenuk, Inc. Current
Director, PhD
2022 – Present · Woodland Hills, CA
AI eye-screening software helps healthcare providers detect diabetic retinopathy.
BI
Biolinq Current
Board Member
2021 – Present
AM
AXA Investment Managers Current
AXA IM Prime Impact Fund Advisor
2020 – Present
GF
Global Health Funds Current
Managing Partner
2020 – Present
AA
Affas Besse Advisors Current
Founding Director
2011 – Present
GC
Global Health Investment Corporation
Senior Advisor
2021 – 2022
AH
Alydia Health
Board Member
2020 – 2021
NL
Novintum Bioscience Ltd
Chief Business Officer
2018 – 2020
BC
Bio Nano Consulting
Industry Board Member
2008 – 2020
ES
Evolva SA
Director Business Development
2010 – 2013
CE
CeQur
Investor Relations
2009
LU
Lumavita
Corporate Development
2009
OP
Orion Healthcare Equity Partners
Owner
2008 – 2009
AV
Atlas Venture
Principal
2002 – 2008
Key Colleagues at Startups
The people Zina Affas Besse works with at each company, as listed on that company's latest Form D.
Eyenuk, Inc. · Form D, Jun 22, 2026
GA
Gaurav Agarwal
Chief Executive Officer and director
Mads Dall
Chairman of the Board
ML
Marie-Louise Little
Director
Kaushal Solanki
Director, PhD
Axena Health, Inc. · Form D, Apr 14, 2026
Jonathan Dean
Director
Samantha Pulliam
CEO and Chief Medical Officer, director
Vincent Ricci
Chief Financial Officer
Ric Cote
Executive Chair
Bret Christensen
Director
JC
Jim O'Connor
General Counsel, Chief Operating Officer, Secretary
SP
Shacey Petrovic
Executive officer and director
Donna Parr
Director
Imbria Pharmaceuticals, Inc. · Form D/A, Dec 16, 2025
PC
Pavan Cheruvu
Director
CD
Charles Dunn
Director
AS
Alvin Shih
Executive officer and director
LR
Luse Rebecca
Director
KH
Ken Horne
Director
KJ
Komal Joshi
Secretary
AL
Andrew Levin
Director